Pharmacological Prophylaxis Doesn’t Cut VTE in Cirrhosis
Low rate of VTE in hospitalized patients with cirrhosis; unaffected by pharmacological prophylaxis
Nodal Radiation Doesn’t Impact Early Breast Cancer Survival
Researchers find it lowers chances of recurrence, but does not boost overall survival
Evidence of Cellular Damage From Computed Tomography
But whether this could trigger cancer or other health issues remains unclear
No Link Found Between Testosterone Therapy and VTE
Finding based on data from more than 30,000 American men, 40 and older
CMS Finalizes Decision to Cover HPV Testing for Cervical Cancer
AAFP encouraged CMS to consider coverage and follow through on proposal
Computerized System Almost Completely Cuts Medical Errors
Most errors eliminated five years after CPOE implementation; no new types of errors detected
ASCO Guidelines: Biomarker Use in Metastatic Breast CA Treatment
Hormone receptor status of metastases should be used to guide tx if supported by clinical scenario
Targeted Prophylaxis Effective in Post-Prostate Biopsy Sepsis
Targeted prophylaxis similarly effective to empirical prophylaxis after transrectal prostate biopsy
Pioglitazone Not Significantly Associated With Bladder Cancer
But research reveals association with pancreatic, prostate cancer
Prostate Cancer Interacts With Comorbidity to Increase VTE Rate
Increased VTE risk among older patients, those with metastases, those who underwent surgery
